Importantly, we are the first to demonstrate that TAK1/NF-κB signaling, as the dominant downstream signaling pathway, is similar to mTOR signaling, inversely modulated by AMPK activity, and involved in ovarian cancer aggressiveness in the intraperitoneal cavity or ascites microenvironment. This evidence concerns the gene PRKAA1 and ovarian carcinoma.